(NasdaqGM:HROW), NASHVILLE, Tenn., Feb. 17, 2026 (GLOBE NEWSWIRE) — Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the launch of a new Direct-to-Prescriber (DTP) cash-pay offering called PharmaPack, which expands the Company's commitment to offering affordable FDA-approved branded products as alternatives to off-label compounded formulations. PharmaPack kits […]

(Neo:ZEFI),(Neo:ZEFI.NE), TORONTO, Feb. 17, 2026 (GLOBE NEWSWIRE) — Dr. Talal A. Debs, Founder and Director of Zefiro Methane Corp. (Cboe: ZEFI) (“Zefiro” or the “Company”), today provided details of important matters to be heard by the British Columbia Securities Commission (“BCSC”) at a proceeding tentatively scheduled for February 25, March 3 and 4, 2026 (the

(TSX:WM),(OTC US:WLBMF),(Other OTC:WLBMF), TORONTO, Feb. 17, 2026 (GLOBE NEWSWIRE) — Wallbridge Mining Company Limited (TSX: WM, OTCQB:WLBMF) (“Wallbridge” or the “Company“) is pleased to announce the initiation of its fully funded 2026 exploration and technical studies programs, highlighted by the commencement of drilling at its 100%-owned Fenelon Gold Project (“Fenelon“) in northwestern Quebec. The 2026

CHICAGO, Feb. 17, 2026 (GLOBE NEWSWIRE) — Amplify ETFs, a leading provider of breakthrough ETF solutions, announces filings for the Amplify LQD Investment Grade 12% Target Income ETF (LQDM) and the Amplify HYG High Yield 10% Target Income ETF (HYGM). Amplify LQD Investment Grade 12% Target Income ETF (LQDM) seeks investment results that generally correspond

(NasdaqGM:AXSM), NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has entered into a settlement agreement with Alkem Laboratories Ltd. (Alkem) resolving patent litigation related to Axsome's product SUNOSI(R) (solriamfetol).

SAN FRANCISCO, Feb. 17, 2026 (GLOBE NEWSWIRE) — Lucidworks, the leader in AI-powered search and product discovery, announced Lucidworks AI Ranking Insights, a new explainability capability within Lucidworks Commerce Studio. “Why is this product ranked here?” It is one of the most common and difficult questions commerce teams face. Modern e-commerce heavily blends rules, boosts,

(NASDAQ:ARVN), NEW HAVEN, Conn., Feb. 17, 2026 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will review fourth quarter and full year 2025 financial results and provide a corporate update during a live webcast on Tuesday, February

(NASDAQ:FTRE), DURHAM, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced it has expanded its executive team. Oren Cohen, MD who previously served as both Fortrea's chief medical officer (CMO) and president of Clinical Pharmacology Services (CPS) is now dedicated to his CMO

(NASDAQ:BCRX), RESEARCH TRIANGLE PARK, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the T.D. Cowen 46th Annual Health Care Conference in Boston on Tuesday, March 3, 2026, at 9:10 a.m. ET. The link to the live audio webcast and replay of the

(NASDAQ:KRYS), $107.1 million in 4Q VYJUVEK revenue and $730.3 million since U.S. launch FDA granted RMAT to KB707 for the treatment of advanced NSCLC and Fast Track Designation to KB111 for the treatment of HHD Strong balance sheet, ending the quarter with $955.9 million in cash and investments PITTSBURGH, Feb. 17, 2026 (GLOBE NEWSWIRE) —